Healthcare professionals throughout the world face a brand-new issue as SARS-CoV-2, a newly discovered coronavirus, spreads around the world. The study's primary goal is to find out how COVID-19 affects cardiac patients, as well as any potential effects on heart tissue and whether cardiologists should be notified. Faisalabad Medical University conducted this descriptive investigation between September 2021 and December 2021. Google Scholar, PubMed, and Web of Science articles published up to June 20th, 2021, were used in this inquiry. Also checked for additional relevant research were referenced references from previously published articles and reviews. People with pre-existing cardiovascular disease (CVD) have a greater vulnerability to contracting COVID-19, and as a result, their condition is more severe, and their prognosis is worse. Several risk factors for cardiovascular disease (CVD) hurt the health of these individuals, but they do not appear to increase the chance of infection. The prevalence of diabetes, cardiovascular disease, and hypertension in 1527 COVID-19 patients was 9.7 percent, 16.4 percent, and 17.1 percent, respectively, according to a meta-analysis of six published studies from China. Patients with COVID-19 are more likely to have pre-existing cardiovascular disease (CVD) or develop new heart dysfunction throughout their illness, based on the illness's striking clinical presentation and its considerable burden.

Keywords: COVID-19, CVD, Patients, Effect